BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 21144038)

  • 1. Characterization of ductal and lobular breast carcinomas using novel prolactin receptor isoform specific antibodies.
    Ginsburg E; Alexander S; Lieber S; Tarplin S; Jenkins L; Pang L; Heger CD; Goldsmith P; Vonderhaar BK
    BMC Cancer; 2010 Dec; 10():678. PubMed ID: 21144038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Re-evaluation of the prolactin receptor expression in human breast cancer.
    Galsgaard ED; Rasmussen BB; Folkesson CG; Rasmussen LM; Berchtold MW; Christensen L; Panina S
    J Endocrinol; 2009 Apr; 201(1):115-28. PubMed ID: 19153125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of the prolactin receptor gene in mammary lobular neoplasia.
    Tran-Thanh D; Arneson NC; Pintilie M; Deliallisi A; Warren KS; Bane A; Done SJ
    Breast Cancer Res Treat; 2011 Jul; 128(1):31-40. PubMed ID: 20658264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alternative splicing to exon 11 of human prolactin receptor gene results in multiple isoforms including a secreted prolactin-binding protein.
    Trott JF; Hovey RC; Koduri S; Vonderhaar BK
    J Mol Endocrinol; 2003 Feb; 30(1):31-47. PubMed ID: 12580759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of a novel and functional human prolactin receptor isoform (deltaS1PRLr) containing only one extracellular fibronectin-like domain.
    Kline JB; Rycyzyn MA; Clevenger CV
    Mol Endocrinol; 2002 Oct; 16(10):2310-22. PubMed ID: 12351696
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIN-1, a putative cytokine highly expressed in normal but not cancerous mammary epithelial cells.
    Krop IE; Sgroi D; Porter DA; Lunetta KL; LeVangie R; Seth P; Kaelin CM; Rhei E; Bosenberg M; Schnitt S; Marks JR; Pagon Z; Belina D; Razumovic J; Polyak K
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9796-801. PubMed ID: 11481438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines.
    Tong D; Schuster E; Seifert M; Czerwenka K; Leodolte S; Zeillinger R
    Breast Cancer Res Treat; 2002 Feb; 71(3):249-55. PubMed ID: 12002343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional characterization of the intermediate isoform of the human prolactin receptor.
    Kline JB; Roehrs H; Clevenger CV
    J Biol Chem; 1999 Dec; 274(50):35461-8. PubMed ID: 10585417
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The short isoform of PRLR suppresses the pentose phosphate pathway and nucleotide synthesis through the NEK9-Hippo axis in pancreatic cancer.
    Nie H; Huang PQ; Jiang SH; Yang Q; Hu LP; Yang XM; Li J; Wang YH; Li Q; Zhang YF; Zhu L; Zhang YL; Yu Y; Xiao GG; Sun YW; Ji J; Zhang ZG
    Theranostics; 2021; 11(8):3898-3915. PubMed ID: 33664869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and modulation of a prolactin receptor mRNA isoform in normal and tumoral human breast tissues.
    Laud K; Gourdou I; Belair L; Peyrat JP; Djiane J
    Int J Cancer; 2000 Mar; 85(6):771-6. PubMed ID: 10709093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of estrogen-stimulated proliferation by a constitutively-active prolactin receptor having lower expression in invasive ductal carcinoma.
    Huang KT; Tan D; Chen KE; Walker AM
    Cancer Lett; 2015 Mar; 358(2):152-160. PubMed ID: 25527452
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of prolactin receptor and prolactin in normal and malignant thyroid: a tissue microarray study.
    Costa P; Catarino AL; Silva F; Sobrinho LG; Bugalho MJ
    Endocr Pathol; 2006; 17(4):377-86. PubMed ID: 17525486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diphenylbutylpiperidine Antipsychotic Drugs Inhibit Prolactin Receptor Signaling to Reduce Growth of Pancreatic Ductal Adenocarcinoma in Mice.
    Dandawate P; Kaushik G; Ghosh C; Standing D; Ali Sayed AA; Choudhury S; Subramaniam D; Manzardo A; Banerjee T; Santra S; Ramamoorthy P; Butler M; Padhye SB; Baranda J; Kasi A; Sun W; Tawfik O; Coppola D; Malafa M; Umar S; Soares MJ; Saha S; Weir SJ; Dhar A; Jensen RA; Thomas SM; Anant S
    Gastroenterology; 2020 Apr; 158(5):1433-1449.e27. PubMed ID: 31786131
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of prolactin and growth hormone receptor genes and their isoforms in the gastrointestinal tract.
    Nagano M; Chastre E; Choquet A; Bara J; Gespach C; Kelly PA
    Am J Physiol; 1995 Mar; 268(3 Pt 1):G431-42. PubMed ID: 7534993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of prolactin and its receptor in human breast carcinoma.
    Reynolds C; Montone KT; Powell CM; Tomaszewski JE; Clevenger CV
    Endocrinology; 1997 Dec; 138(12):5555-60. PubMed ID: 9389544
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical Activity of the Novel Anti-Prolactin Receptor (PRLR) Antibody-Drug Conjugate REGN2878-DM1 in PRLR-Positive Breast Cancers.
    Kelly MP; Hickey C; Makonnen S; Coetzee S; Jalal S; Wang Y; Delfino F; Shan J; Potocky TB; Chatterjee I; Andreev J; Kunz A; D'Souza C; Giurleo JT; Nittoli T; Trail PA; Thurston G; Kirshner JR
    Mol Cancer Ther; 2017 Jul; 16(7):1299-1311. PubMed ID: 28377489
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prolactin receptor in primary hyperparathyroidism--expression, functionality and clinical correlations.
    Haglund F; Lu M; Vukojević V; Nilsson IL; Andreasson A; Džabić M; Bränström R; Höög A; Juhlin CC; Larsson C
    PLoS One; 2012; 7(5):e36448. PubMed ID: 22606260
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of transient signaling via short and long prolactin receptor isoforms in female and male sensory neurons.
    Belugin S; Diogenes AR; Patil MJ; Ginsburg E; Henry MA; Akopian AN
    J Biol Chem; 2013 Nov; 288(48):34943-55. PubMed ID: 24142695
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular expression of growth hormone and prolactin receptors in human breast disorders.
    Mertani HC; Garcia-Caballero T; Lambert A; Gérard F; Palayer C; Boutin JM; Vonderhaar BK; Waters MJ; Lobie PE; Morel G
    Int J Cancer; 1998 Apr; 79(2):202-11. PubMed ID: 9583737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prolactin Receptor Expression is an Independent Favorable Prognostic Marker in Human Breast Cancer.
    Hachim IY; Hachim MY; Lopez VM; Lebrun JJ; Ali S
    Appl Immunohistochem Mol Morphol; 2016 Apr; 24(4):238-45. PubMed ID: 26317306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.